RANI position history
The shares of Rani Therapeutics (RANI) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 78,000 shares, $105K, <0.01% of portfolio, New
- 2026 Q1: 78,000 shares, $57K, <0.01% of portfolio
- 2026 Q2: 20,700 shares, $16K, <0.01% of portfolio, Reduce −73.5%
- 2026 Q3: 20,700 shares, $16K, <0.01% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|